Jump to content

  • Set Your Location
  • Sign in or Enroll
Set Your LocationSet Your Location
  • Sign in or Enroll
    • Open I want to choose my medical group or hospital
    • Clear my location
Change Location
Sutter Health
  • Video Visits
  • Find Doctors
  • Find Locations
  • Treatments & Services
    • Video Visits
    • Find Doctors
    • Find Locations
    • Treatments & Services
    • COVID-19 Resources
    • Pay a Bill
    • Symptom Checker
    • Get Care Today
    • Health & Wellness
    • Classes & Events
    • Research & Clinical Trials
    • For Patients
    • About Sutter Health
    • Giving
    • Volunteering
    • Careers
    • News
    • For Medical Professionals
    • Other Business Services
Close Search
  • Home
  • Palo AltoAll Cities
  • Services
  • Liver Care
  • Hepatitis C Care
Content

Hepatitis C Care in Palo Alto

It's care that works for you. Find out about convenient care options for Hepatitis C Care Services in Palo Alto at Sutter Health. We're taking extra precautions every day to help keep patients, staff and providers safe.
African-American man having blood drawn

Connect with a Liver Specialist

Hepatitis C Care

Hepatitis C, known as "the silent epidemic" because many people have mild or no symptoms, can lead to cirrhosis and ultimately liver cancer. It’s the leading cause of liver transplant in the United States.

Exciting advances have been made in the treatment of hepatitis C, and Sutter Health is in the vanguard in hepatitis C management, treatment and research. California Pacific’s Liver Disease Management and Transplant Center serves as a hub for viral hepatitis research, offering clinical trials of new antiviral agents.

A blood-borne virus, hepatitis C risk factors include multiple blood transfusions prior to 1990 (the virus was identified in 1989), intravenous drug use, body tattoos and multiple sex partners. Persons who have served in the military, healthcare workers and women who had cesarean sections prior to 1990 have higher risks of infection.

Screening

Identifying carriers is a high priority for Medicare, which covers one hepatitis C screening for anyone:

  • Ages 18 to 79
  • Who had blood transfusions before 1992
  • At high risk for infection due to current or past intravenous drug use

Medicare requires that your primary care doctor order the hepatitis virus panel. If antibodies are detected, you may be referred to a liver specialist, who will order further tests.

Disease Management

If you have chronic hepatitis C, a liver specialist can monitor the progress of your disease using liver function tests and, if necessary, liver biopsy to assess the extent of fibrosis, a precursor to cirrhosis. A noninvasive imaging exam called Fibroscan measures the stiffness of the liver and is another way to assess the extent of fibrosis.

Therapy

There are four stages of fibrosis. If you have stage 0 or 1 fibrosis, you have mild hepatitis C. If you have stage 3 or 4, you are at risk for developing cirrhosis. Specialists will work with you to discuss therapy with antiviral drugs to reduce the virus’s ability to reproduce.

Current standard treatment combines medications called Pegylated interferon-alpha-2a or Pegylated interferon-alpha-2b (brand names Pegasys® or PEG-Intron®) and antiviral ribavirin, administered for 24 or 48 weeks.

Doctors generally recommend treatment for people with proven hepatitis C virus infection, persistently abnormal liver function tests and a liver biopsy that shows significant fibrosis. Therapy clears the virus in 70 to 80 percent of those infected with HCV genotypes 2 and 3 and in about 45 percent of those infected with genotype 1.

Only about 15 percent of hepatitis C-infected patients will go on to develop cirrhosis during their lifetime. The majority of people with hepatitis C will never need a liver transplant.

In Your Corner

Doctor checking on a patient at the ER

Defending the Liver from Cirrhosis

Many liver diseases, hepatitis C included, can cause cirrhosis, which negatively impacts your liver’s ability to perform its many functions. With an early diagnosis and management of your disease, liver specialists in the Sutter Health network can help you stop and sometimes reverse the damage.

Patient Stories

Compassionate Care Makes the Difference for One Family

A patient’s husband talks about the kind, attentive, top-notch care his wife received at Sutter Lakeside.

View All Stories

Primary Biliary Cholangitis (PBC) Research

Sutter Health Primary Biliary Cholangitis (PBC) Research
Primary biliary cholangitis (PBC) is a chronic autoimmune disease with injury and inflammation to the small bile ducts in the liver. This injury can eventually cause the bile ducts to collapse. Without bile ducts, bile (a digestive enzyme) builds up and causes liver damage.

Sutter Health Primary Biliary Cholangitis (PBC) Research Sutter Health Primary Biliary Cholangitis (PBC) Research

Services Near Palo Alto

Palo Alto Medical Foundation

Palo Alto Medical Foundation

Mills-Peninsula Medical Center

Mills-Peninsula Medical Center

Alta Bates Summit Medical Center

Alta Bates Summit Medical Center

Sutter Gould Medical Foundation

Sutter Gould Medical Foundation

Sutter Auburn Faith Hospital

Sutter Auburn Faith Hospital

View All Related Locations

  • Contact Us
  • Find Doctors
  • Find Locations
  • Request Medical Records
  • Make a Gift
Sign in to My Health Online

Billing and Insurance

  • Pay a Bill
  • Accepted Health Plans
  • Estimate Costs
  • Medicare Advantage

About Sutter

  • About Our Network
  • Community Benefit
  • Annual Report
  • News

Our Team

  • For Employees
  • For Medical Professionals
  • For Vendors
  • For Volunteers

Careers

  • Jobs at Sutter
  • Physician Jobs
  • Graduate Medical Education

Copyright © 2023 Sutter Health. All rights reserved. Sutter Health is a registered trademark of Sutter Health ®, Reg. U.S. Patent & Trademark office.

  • ADA Accessibility
  • Privacy
  • Do Not Sell My Personal Information
  • LinkedIn Opens new window
  • YouTube Opens new window
  • Facebook Opens new window
  • Twitter Opens new window
  • Instagram Opens new window
  • Glassdoor Opens new window

Cookie Policy

We use cookies to give you the best possible user experience. By continuing to use the site, you agree to the use of cookies. Privacy Policy Cookie Preferences

Privacy Policy Cookie Preferences